350 million patients globally have rare genetic diseases, including 3.5 million in the UK.
Leukodystrophies are devastating rare diseases with limited treatment and research on leukodystrophy is under-represented in the UK. A more collaborative and united approach in leukodystrophy research will bring together our national experts and allow rapid and efficient progress towards therapeutic interventions.
O U R G O A L S:
To unite researchers and clinicians working on leukodystrophies, promote collaborative projects and develop therapies.
Company Details
- Founded
- 2022
- Industry
- Non-Profit Organizations
- Website
- http://www.leukolabs.org
- Keywords
- leukodystrophy and network.
Leukolabs Questions
Leukolabs's website is http://www.leukolabs.org
Leukolabs's LinkedIn profile is https://www.linkedin.com/company/leukolabs
Leukolabs's industry is
Non-profit Organizations
Leukolabs's top competitors are
Atom Advantage,
World Leukodystrophy Alliance,
Presend,
Huntsville Coca-Cola,
Leukolab,
The Pmd Foundation,
Alex The Leukodystrophy Charity (Alex Tlc),
Senseily,
Spot - Social Fitness App,
Global Leukodystrophy Initiative.
Leukolabs's categories are Non-profit Organizations
Leukolabs's founding year is 2022
